Betamethasone valerate foam for treatment of nonscalp psoriasis

Journal of Cutaneous Medicine and Surgery
Linda SteinU Chaudhari

Abstract

Although betamethasone valerate (BMV) foam, 0.12% (Luxiq, Connectics Corporation, Palo Alto, CA) is approved by the Food and Drug Administration for the treatment of corticosteroid-responsive scalp dermatoses, no data are available for its use on nonscalp psoriasis. We evaluated the safety and efficacy of BMV foam in treating psoriatic lesions at nonscalp sites. We conducted a randomized, double-blind, placebo-controlled, paired-comparison, split-body study of 40 patients with mild to moderate plaque-type psoriasis. Patients applied BMV foam and placebo foam twice daily for 12 weeks. At the end of the treatment period, 70% of patients had greater than 50% improvement of lesions on their active foam-treated side compared with 24% of patients with similar improvement on their placebo foam-treated side. Adverse effects were limited to temporary stinging, burning, or itching in several patients. Three patients (7.5%) withdrew because of stinging or itching. The results indicate that BMV foam is effective against nonscalp psoriasis. Twice-daily applications are well tolerated, compliance exceeds 90%, cosmetic characteristics are acceptable, and the medication may reduce the need for multiple prescriptions.

Citations

May 15, 2007·Archives of Dermatological Research·A NastB Rzany
Feb 22, 2012·Archives of Dermatological Research·A NastUNKNOWN Berufsverband Deutscher Dermatologen
Apr 12, 2003·American Journal of Clinical Dermatology·Steven R Feldman, Tamara S Housman
Apr 3, 2013·Expert Opinion on Drug Delivery·Sara Caliço RaposoHelena Margarida Ribeiro
Jul 22, 2010·Expert Opinion on Drug Delivery·Amitava Mitra, Yunhui Wu
Jun 24, 2010·Expert Opinion on Pharmacotherapy·Philip M Laws, Helen S Young
May 4, 2010·International Journal of Pharmaceutics·A Arzhavitina, H Steckel
Jan 31, 2006·Journal of the European Academy of Dermatology and Venereology : JEADV·A PacificoK Peris
May 26, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·E CastelaJ P Ortonne
May 14, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·P C M van de KerkhofUNKNOWN International Psoriasis Council
Jun 22, 2005·Journal of the American Academy of Dermatology·Xinfan HuangLincoln Krochmal
Jun 22, 2005·Journal of the American Academy of Dermatology·Linda Stein
Jun 22, 2005·Journal of the American Academy of Dermatology·William Abramovits
Apr 12, 2012·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alexander NastUNKNOWN Berufsverband Deutscher Dermatologen (BVDD)
Jul 20, 2010·The Journal of Pharmacy and Pharmacology·Yanjun ZhaoMarc B Brown
Jul 20, 2010·The Journal of Pharmacy and Pharmacology·Thakur Raghu Raj SinghRyan F Donnelly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.